Pediatric Tuberculosis Treatment Guidelines

Introduction to Treatment Regimens

• The American Academy of Pediatrics recommends a 6-month course consisting of isoniazid, rifampin, and pyrazinamide for the first 2 months, followed by isoniazid and rifampin for 4 months, with ethambutol added as a fourth drug in the initial phase when drug resistance is a concern, for pediatric tuberculosis treatment 1, 2

Treatment Phases and Medications

• The initial phase (2 months) of pediatric tuberculosis treatment includes isoniazid (10-15 mg/kg/day, up to 300 mg), rifampin (10-20 mg/kg/day, up to 600 mg), pyrazinamide (15-30 mg/kg/day, up to 2 g), and ethambutol (15-25 mg/kg/day) when drug resistance is suspected 1, 2
• The continuation phase (4 months) of pediatric tuberculosis treatment includes isoniazid and rifampin only 1, 2

Special Considerations

• The American Academy of Pediatrics recommends including ethambutol in the initial regimen for children with tuberculosis 1, 2
• For patients with compromised immune systems, treatment duration should be extended to at least 9 months, with more frequent monitoring required, and once-weekly or twice-weekly regimens are not recommended in patients with CD4+ counts <100/mm³ 2
• In pregnancy, standard treatment can be used, but streptomycin should be avoided due to risk of fetal ototoxicity, and routine use of pyrazinamide is not recommended due to inadequate teratogenicity data 3, 4, 5
• For patients on dialysis, medications should be administered after dialysis 5
• HIV-infected patients may have higher mortality despite treatment, and considerations for drug absorption issues and potential need for therapeutic drug monitoring should be taken into account, with once-weekly isoniazid-rifapentine and twice-weekly isoniazid-rifampin/rifabutin not recommended in patients with CD4+ counts <100/mm³ 3, 6, 5

Drug Penetration and Central Nervous System Involvement

• The following drugs penetrate well into the cerebrospinal fluid (CSF):

  Drug	CSF Penetration
  Isoniazid	Good
  Pyrazinamide	Good
  Prothionamide/Ethionamide	Good
  Fluoroquinolones	Good
  Rifampicin	Moderate
  Ethambutol	Poor
  Streptomycin	Poor

• Isoniazid, pyrazinamide, and ethionamide penetrate well into cerebrospinal fluid (CSF), while rifampin penetrates less well, and streptomycin and ethambutol only penetrate adequately when meninges are inflamed 4

Treatment Monitoring and Response

• Treatment completion is determined by the number of doses taken, not just duration, and the full 6-month regimen should be completed within 9 months, with clinical and radiographic improvement as primary indicators of response for extrapulmonary tuberculosis 2, 5
• Directly observed therapy (DOT) is strongly recommended for all pediatric tuberculosis cases to ensure adherence 2
• Regular monitoring of cerebrospinal fluid (CSF) parameters, neurological status assessment, liver function tests, and visual acuity and color discrimination testing for patients on ethambutol are essential for effective management, especially early in treatment, to assess response and potential toxicities 3, 6, 2
• More frequent monitoring of liver function is required: weekly for first two weeks, and every two weeks thereafter during initial phase 4
• Adjunctive corticosteroid therapy is strongly recommended based on evidence showing mortality benefit, with dexamethasone 12 mg/day for adults (8 mg/day for children <25 kg) for the initial 3 weeks, then tapered gradually over the following 3 weeks, as supported by the European Respiratory Society/European Centre for Disease Prevention and Control, American Thoracic Society, CDC, and Infectious Diseases Society of America 3, 6, 2
• The standard treatment for tuberculous meningitis consists of a 12-month regimen with isoniazid, rifampin, pyrazinamide, and ethambutol for the initial 2 months, followed by isoniazid and rifampin for 10 months, along with adjunctive corticosteroid therapy using dexamethasone tapered over 6-8 weeks, as recommended by the American Thoracic Society, CDC, and Infectious Diseases Society of America with strong recommendation based on moderate certainty evidence showing mortality benefit 3, 6
• Parenteral forms of isoniazid, rifampin, and fluoroquinolones are available for patients with altered mental status who cannot take oral medications 6
• Repeated lumbar punctures should be performed to monitor changes in CSF cell count, glucose, and protein levels, especially important early in the course of therapy 6
• Prompt neurosurgical referral for hydrocephalus, tuberculous cerebral abscess, or paraparesis is recommended 6